FITC Anti-Ly6g antibody [EPR22909-135],Abcam,AB322293

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Mouse, Mouse

Application

Flow Cyt

Conjugate

FITC

Platform ID

BAB119153337

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameFITC Anti-Ly6g antibody [EPR22909-135]
Cat. No.AB322293
HostRabbit
IsotypeIgG
ReactivityMouse, Mouse
ConjugationFITC
ApplicationFlow Cyt
ClonalityMonoclonal
Clone NumberEPR22909-135
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data See full target information Ly6g

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.